vs
BICYCLE THERAPEUTICS PLC(BCYC)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是BICYCLE THERAPEUTICS PLC的1.6倍($78.6M vs $48.0M),BICYCLE THERAPEUTICS PLC净利率更高(-42.0% vs -178.3%,领先136.3%),BICYCLE THERAPEUTICS PLC同比增速更快(1193.3% vs 0.4%),Repay Holdings Corp自由现金流更多($23.2M vs $-19.9M),过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高(56.7% vs -1.3%)
Bicycle Therapeutics是一家临床阶段生物制药企业,专注于开发双环肽类创新疗法以解决未被满足的医疗需求,核心管线覆盖肿瘤、罕见病与免疫疾病领域,在欧美布局运营,与全球头部药企达成战略合作推进候选药物落地。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
BCYC vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.6倍
$48.0M
营收增速更快
BCYC
高出1192.9%
0.4%
净利率更高
BCYC
高出136.3%
-178.3%
自由现金流更多
RPAY
多$43.1M
$-19.9M
两年增速更快
BCYC
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $48.0M | $78.6M |
| 净利润 | $-20.2M | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | -51.5% | -182.2% |
| 净利率 | -42.0% | -178.3% |
| 营收同比 | 1193.3% | 0.4% |
| 净利润同比 | 61.1% | -3304.1% |
| 每股收益(稀释后) | $-0.29 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BCYC
RPAY
| Q4 25 | $48.0M | $78.6M | ||
| Q3 25 | $11.7M | $77.7M | ||
| Q2 25 | $2.9M | $75.6M | ||
| Q1 25 | $10.0M | $77.3M | ||
| Q4 24 | $3.7M | $78.3M | ||
| Q3 24 | $2.7M | $79.1M | ||
| Q2 24 | $9.4M | $74.9M | ||
| Q1 24 | $19.5M | $80.7M |
净利润
BCYC
RPAY
| Q4 25 | $-20.2M | $-140.1M | ||
| Q3 25 | $-59.1M | $-6.4M | ||
| Q2 25 | $-79.0M | $-102.3M | ||
| Q1 25 | $-60.8M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-50.8M | $3.2M | ||
| Q2 24 | $-39.8M | $-4.1M | ||
| Q1 24 | $-26.6M | $-5.2M |
毛利率
BCYC
RPAY
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 77.8% | ||
| Q2 24 | — | 78.2% | ||
| Q1 24 | — | 76.2% |
营业利润率
BCYC
RPAY
| Q4 25 | -51.5% | -182.2% | ||
| Q3 25 | -558.6% | -3.9% | ||
| Q2 25 | -2965.8% | -138.7% | ||
| Q1 25 | -703.7% | -4.7% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | -2385.9% | -0.9% | ||
| Q2 24 | -498.3% | -4.6% | ||
| Q1 24 | -162.4% | -3.1% |
净利率
BCYC
RPAY
| Q4 25 | -42.0% | -178.3% | ||
| Q3 25 | -503.7% | -8.3% | ||
| Q2 25 | -2703.8% | -135.2% | ||
| Q1 25 | -608.9% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | -1898.4% | 4.1% | ||
| Q2 24 | -425.3% | -5.4% | ||
| Q1 24 | -136.0% | -6.5% |
每股收益(稀释后)
BCYC
RPAY
| Q4 25 | $-0.29 | $-1.68 | ||
| Q3 25 | $-0.85 | $-0.08 | ||
| Q2 25 | $-1.14 | $-1.15 | ||
| Q1 25 | $-0.88 | $-0.09 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | $-0.74 | $0.03 | ||
| Q2 24 | $-0.77 | $-0.04 | ||
| Q1 24 | $-0.62 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $610.0M | $484.4M |
| 总资产 | $717.6M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
BCYC
RPAY
| Q4 25 | $628.1M | $115.7M | ||
| Q3 25 | $648.3M | $95.7M | ||
| Q2 25 | $721.5M | $162.6M | ||
| Q1 25 | $793.0M | $165.5M | ||
| Q4 24 | $879.5M | $189.5M | ||
| Q3 24 | $890.9M | $168.7M | ||
| Q2 24 | $961.4M | $147.1M | ||
| Q1 24 | $457.0M | $128.3M |
总债务
BCYC
RPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | $30.9M | $435.6M | ||
| Q1 24 | $30.8M | $434.9M |
股东权益
BCYC
RPAY
| Q4 25 | $610.0M | $484.4M | ||
| Q3 25 | $618.5M | $616.9M | ||
| Q2 25 | $668.9M | $633.7M | ||
| Q1 25 | $740.3M | $755.7M | ||
| Q4 24 | $793.1M | $761.3M | ||
| Q3 24 | $831.0M | $754.7M | ||
| Q2 24 | $873.8M | $815.4M | ||
| Q1 24 | $356.0M | $813.8M |
总资产
BCYC
RPAY
| Q4 25 | $717.6M | $1.2B | ||
| Q3 25 | $764.0M | $1.3B | ||
| Q2 25 | $832.2M | $1.4B | ||
| Q1 25 | $883.9M | $1.5B | ||
| Q4 24 | $956.9M | $1.6B | ||
| Q3 24 | $996.7M | $1.6B | ||
| Q2 24 | $1.1B | $1.5B | ||
| Q1 24 | $547.1M | $1.5B |
负债/权益比
BCYC
RPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | 0.04× | 0.53× | ||
| Q1 24 | 0.09× | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $23.2M |
| 自由现金流率自由现金流/营收 | -41.5% | 29.6% |
| 资本支出强度资本支出/营收 | 1.2% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-252.0M | $90.7M |
8季度趋势,按日历期对齐
经营现金流
BCYC
RPAY
| Q4 25 | $-19.3M | $23.3M | ||
| Q3 25 | $-71.2M | $32.2M | ||
| Q2 25 | $-72.8M | $33.1M | ||
| Q1 25 | $-86.4M | $2.5M | ||
| Q4 24 | $-164.7M | $34.3M | ||
| Q3 24 | $-39.8M | $60.1M | ||
| Q2 24 | $-44.6M | $31.0M | ||
| Q1 24 | $-70.9M | $24.8M |
自由现金流
BCYC
RPAY
| Q4 25 | $-19.9M | $23.2M | ||
| Q3 25 | $-71.8M | $32.1M | ||
| Q2 25 | $-73.3M | $33.0M | ||
| Q1 25 | $-87.0M | $2.4M | ||
| Q4 24 | $-166.0M | $34.0M | ||
| Q3 24 | $-40.3M | $59.8M | ||
| Q2 24 | $-45.0M | $30.5M | ||
| Q1 24 | $-70.9M | $24.7M |
自由现金流率
BCYC
RPAY
| Q4 25 | -41.5% | 29.6% | ||
| Q3 25 | -612.3% | 41.3% | ||
| Q2 25 | -2509.7% | 43.6% | ||
| Q1 25 | -871.7% | 3.0% | ||
| Q4 24 | -4475.7% | 43.5% | ||
| Q3 24 | -1504.7% | 75.6% | ||
| Q2 24 | -481.2% | 40.7% | ||
| Q1 24 | -362.9% | 30.6% |
资本支出强度
BCYC
RPAY
| Q4 25 | 1.2% | 0.1% | ||
| Q3 25 | 5.7% | 0.2% | ||
| Q2 25 | 17.1% | 0.1% | ||
| Q1 25 | 6.1% | 0.2% | ||
| Q4 24 | 33.3% | 0.3% | ||
| Q3 24 | 16.3% | 0.3% | ||
| Q2 24 | 4.5% | 0.6% | ||
| Q1 24 | 0.1% | 0.1% |
现金转化率
BCYC
RPAY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCYC
暂无分部数据
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |